Patents by Inventor David Monda

David Monda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080213812
    Abstract: Methods and compositions are provided for modulating, e.g., increasing or decreasing, the expression of telomerase reverse transcriptase (TERT). In the subject methods, the binding interaction of the TERT Site C repressor site with a Site C repressor protein complex made up of one or more proteins is modulated to achieve the desired change in TERT expression. A feature of the subject invention is that the target Site C repressor protein complex includes an LSF protein. The subject methods and compositions find use in a variety of different applications, including the immortalization of cells, the production of reagents for use in life science research, therapeutic applications; therapeutic agent screening applications; and the like.
    Type: Application
    Filed: January 18, 2008
    Publication date: September 4, 2008
    Inventors: William H. Andrews, Laura Briggs, Christopher Foster, Hamid Mohammadpour, Stephanie Fraser, David Monda, Lancer Brown, Frederick M. Hahn, Ronald Pruzan, David Schooley, Jason March